Response to Pembrolizumab in Metastatic Melanoma: Computed Tomography Texture Analysis as a Predictive Biomarker
Clinical trial NCT02740920 · TERMINATED
Trial details
- NCT number
- NCT02740920
- Sponsor
- Canadian Cancer Trials Group
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-10
- Primary completion
- 2019-03-22
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.